RecruitingNCT05775458

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Role of Glutamate-mediate Excitotoxicity in Invasion and Progression Processes of Glioblastoma Multiforme


Sponsor

IRCCS San Raffaele

Enrollment

50 participants

Start Date

Jun 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Gliomas are the most frequent type of primary brain tumors in adults; among them glioblastoma multiforme (GBM) is the most malignant, being associated with the worst prognosis. Glutamate (Glu) is an aminoacid, responsible for essential functions in the Central Nervous System (CNS), acting both as metabolite and neurotransmitter. It is essential for regulating cellular metabolism and developmental synaptogenesis, cellular migration, differentiation and death. Recent scientific evidences have demonstrated alteration in Glu synthesis and signaling being directly involved in GBM growth and invasion


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Adult patients with a brain lesion suspected for GBM, candidate to gross total tumor resection (GTR), followed by radiotherapy and chemotherapy (concomitant and adjuvant).
  • Patient able to provide informed consent.

Exclusion Criteria4

  • Age \< 18 years
  • Liver disease
  • Severe anemia (Hb \<8mg/dl)
  • Pregnancy

Interventions

DIAGNOSTIC_TESTBlood, CSF and tumor samples

Blood, CSF and brain tissue sampling of Glu and Glu regulatory proteins.


Locations(1)

IRCCS San Raffaele Scientific Institute

Milan, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05775458


Related Trials